The FDA approved Mounjaro today to lower the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who are at high risk for those events. That is a real expansion, and for a lot of people it is genuinely good news. It is also going to be reported badly by […]
Not one of them tested an injury. I pulled every record in FDA’s July 2026 review and the registries behind it.
An ApoB of 60 mg/dL sits at about the 10th percentile of untreated American adults, lower than roughly nine of every ten, under even the goal the 2026 guideline reserves for its high-risk patients, and inside the range the longevity crowd treats as the destination. By every framework I can find, a 60 is a
An ApoB of 90 mg/dL is the most average result an American adult can get. ApoB is in effect a particle count: every particle that can push cholesterol into an artery wall carries exactly one copy of it. In the National Lipid Association’s percentile table for untreated US adults, 90 is the 50th percentile. Whether
My first ApoB result was 95 mg/dL, in May 2025. Labcorp flagged it high, because Labcorp’s reference range tops out at 90. Cleveland Clinic publishes a normal range for men of 66 to 133, so the same tube of blood at a different lab would have come back with no flag at all. Whether my
I priced one standalone ApoB test at thirteen services on the same day. The advertised prices start at $11; the checkout totals mostly start at $24.
Melanoma flips male after 50 and keeps climbing. Merck and Moderna announced a Phase 3 win with no efficacy numbers attached, so here is what is actually known about the drug, and what is worth knowing about your own skin.
I inject a drug made by a compounding pharmacy with a warning letter to its name. Reading that letter is what taught me how to buy every drug I take.
Sam Sulek’s peptide company sold retatrutide in a pre-filled pen “for research use only,” while a site under the same NewBioRx branding walked you through putting it in your body. On Sunday afternoon the pen vanished from the store and the instructions site went dark. The vials are still for sale.
Bank of America defends $250M a year in GLP-1 spending. Starbucks cuts it. Inside the employer split over weight-loss drug coverage, and what it means for you.
